Surgical Outcomes of Endoscopic Transsphenoidal Pituitary Surgery
DOI:
https://doi.org/10.36552/pjns.v29i1.1063Keywords:
Adenoma, Endoscopic trans-sphenoidal, Microscopic trans-sphenoidal, Pituitary adenomaAbstract
Introduction: Pituitary adenoma are common benign tumors of the brain and causes significant symptoms due to hormonal imbalances (mostly functional pituitary adenoma) and their mass effect on surrounding structures (majority of nonfunctional pituitary adenoma). The aim of this study was to find out the surgical outcomes of endoscopic trans-sphenoidal approach in terms of safety, effectiveness, per-op and post-op complications and relieve of symptoms.
Methodology: This study was conducted at Ali Institute of Neurosciences and Irfan General Hospital, Peshawar, from April 2019 to April 2021. Patients diagnosed with pituitary adenomas (confirmed by MRI) and treated with the endoscopic trans-sphenoidal approach were included. Demographic data was collected, and outcomes were assessed post-surgery and at 6-month follow-up. Data were analyzed using SPSS version-26.
Results: The majority of participants were male (65%) with a mean age of 31 years (range 22-28). Most patients presented with headaches (76%) and visual disturbances (60%), while 53% had hormonal imbalances. Post-surgery 100% reported headache relief 87% showed visual improvements measured by Humphrey perimeter and visual acuity tests, and 97% had favorable endocrinological outcomes based on hormonal profile assessments.
Conclusion: When treating pituitary adenoma, the endoscopic trans-sphenoidal approach is a safe and successful surgical technique that is linked to better patient results and satisfaction. Complications from the operation include intercavernous sinus hemorrhage, diabetes insipidus, hypopituitarism and CSF leakage.
Keywords: Adenoma, Endoscopic trans-sphenoidal, Microscopic trans-sphenoidal, Pituitary adenoma
References
References:
Hauser BM, Lau A, Gupta S, Bi WL, Dunn IFJFie. The epigenomics of pituitary adenoma. 2019;10:290. doi: 10.3389/fendo.2019.00290.
Lim CT, Korbonits MKJEP. Update on the clinicopathology of pituitary adenomas. 2018;24(5):473-88. doi: 10.4158/EP-2018-0034
Sharifi G, Sabahi M, Amin A, Dilmaghani NA, Nejad AM, Davoudi Z, et al. Patterns of extrasellar invasive growth of pituitary adenomas with normal sellar cavity size. 2021;209:106942. doi: 10.1016/j.clineuro.2021.106942
Gan L, Ma J, Feng F, Wang Y, Cui J, Guo X, et al. The predictive value of suprasellar extension for visual function evaluation in Chinese patients with nonfunctioning pituitary adenoma with optic chiasm compression. 2018;116:e960-e7. doi: 10.1016/j.wneu.2018.05.141
Ntali G, Wass JAJP. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. 2018;21(2):111-8. doi: 10.1007/s11102-018-0869-3
Shijo K, Yoshimura S, Mori F, Yamamuro S, Sumi K, Oshima H, et al. Pituitary apoplexy accompanying temporal lobe seizure as a complication. 2020;138:153-7. doi: 10.1016/j.wneu.2020.02.148
Jamaluddin MA, Patel BK, George T, Gohil JA, Biradar HP, Kandregula S, et al. Endoscopic Endonasal Approach for Giant Pituitary Adenoma Occupying the Entire Third Ventricle: Surgical Results and a Review of the Literature. 2021;154:e254-e63. doi: 10.1016/j.wneu.2021.07.022
Kang BM, Oh HJ, Ryu KH, Ahn JM. Treatment of pituitary adenoma with spontaneous cerebrospinal rhinorrhea using nasoseptal flap, two case reports. Surgical neurology international. 2022;13:262. doi: 10.25259/SNI_61_2022
Hayashi Y, Sasagawa Y, Oishi M, Kita D, Tanaka S, Ueda F, et al. Directional regulation of extrasellar extension by sellar dura integrity and intrasphenoidal septation in pituitary adenomas. 2019;122:e130-e8. doi: 10.1016/j.wneu.2018.09.127
Araujo-Castro M, Berrocal VR, Pascual-Corrales EJH. Pituitary tumors: epidemiology and clinical presentation spectrum. 2020;19(2):145-55. doi: 10.1007/s42000-019-00168-8
Almeida JP, Sanchez MM, Karekezi C, Warsi N, Fernández-Gajardo R, Panwar J, et al. Pituitary apoplexy: results of surgical and conservative management clinical series and review of the literature. 2019;130:e988-e99. doi: 10.3389/fendo.2019.00290
Tampourlou M, Fountas A, Ntali G, Karavitaki NJP. Mortality in patients with non-functioning pituitary adenoma. 2018;21(2):203-7. doi: 10.1007/s11102-018-0863-9
Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, et al. Clinical Biology of the Pituitary Adenoma. Endocrine Reviews. 2022. doi: 10.1210/endrev/bnac010
Mehta GU, Lonser RR. Management of hormone-secreting pituitary adenomas. Neuro-Oncology. 2016;19(6):762-73. doi: 10.1093/neuonc/now130
Banskota S, Adamson DJB. Pituitary Adenomas: From Diagnosis to Therapeutics. 2021;9(5). doi: 10.3390/biomedicines9050494
Herse P. Pituitary macroadenoma: a case report and review. Clinical and experimental optometry. 2014;97(2):125-32. doi: 10.1111/cxo.12099
Salama MM, Rady MRJEJoN. Transcranial approaches for pituitary adenomas: current indications and clinical and radiological outcomes. 2021;36(1). doi.org/10.1186/s41984-021-00117-x
Micko A, Agam MS, Brunswick A, Strickland BA, Rutkowski MJ, Carmichael JD, et al. Treatment strategies for giant pituitary adenomas in the era of endoscopic transsphenoidal surgery: a multicenter series. 2021;136(3):776-85. doi: 10.3171/2021.1.JNS203982
Chaudhary V, Bano S. Imaging of the pituitary: Recent advances. Indian journal of endocrinology and metabolism. 2011;15 Suppl 3(Suppl3):S216-23. doi: 10.4103/2230-8210.84871
Araujo-Castro M, Cancela AA, Vior C, Pascual-Corrales E, Berrocal VRJFiO. Radiological Knosp, Revised-Knosp, and Hardy–Wilson Classifications for the Prediction of Surgical Outcomes in the Endoscopic Endonasal Surgery of Pituitary Adenomas: Study of 228 Cases. 2021;11. doi: 10.3389/fonc.2021.807040
Rutkowski M, Chang K, Cardinal T, Du R, Tafreshi A, Donoho D, et al. Development and clinical validation of a grading system for pituitary adenoma consistency. 2020;134(6):1800-7. doi: 10.3171/2020.4.JNS193288
Acitores Cancela A, Rodríguez Berrocal V, Pian H, Martínez San Millán JS, Díez JJ, Iglesias PJH. Clinical relevance of tumor consistency in pituitary adenoma. 2021;20(3):463-73. doi: 10.1007/s42000-021-00302-5
Ortiz LD, Syro LV, Scheithauer BW, Rotondo F, Uribe H, Fadul CE, et al. Temozolomide in aggressive pituitary adenomas and carcinomas. 2012;67:119-23. doi: 10.6061/clinics/2012(sup01)20
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mumtaz Ali, Ramzan Hussain, Hanif Ur Rahman, Sajid Razzaq, Abdur Raheem, Muhammad Aneeq, Yasir Ashraf, Jabir ShahThe work published by PJNS is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Copyrights on any open access article published by Pakistan Journal of Neurological Surgery are retained by the author(s).
